Cargando…

Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants

BACKGROUND: There is a wide range of severity of respiratory syncytial viral (RSV) disease in previously healthy infants. Host factors have been well demonstrated to contribute to disease severity differences. However the possibility of disease severity differences being produced by factors intrinsi...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Tonya M, Roddam, Philippa L, Harrison, Lisa M, Aitken, Jody A, DeVincenzo, John P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603536/
https://www.ncbi.nlm.nih.gov/pubmed/26473163
http://dx.doi.org/10.4172/2327-5073.1000206
_version_ 1782394915940990976
author Thompson, Tonya M
Roddam, Philippa L
Harrison, Lisa M
Aitken, Jody A
DeVincenzo, John P
author_facet Thompson, Tonya M
Roddam, Philippa L
Harrison, Lisa M
Aitken, Jody A
DeVincenzo, John P
author_sort Thompson, Tonya M
collection PubMed
description BACKGROUND: There is a wide range of severity of respiratory syncytial viral (RSV) disease in previously healthy infants. Host factors have been well demonstrated to contribute to disease severity differences. However the possibility of disease severity differences being produced by factors intrinsic to the virus itself has rarely been studied. METHODS: Low-passage isolates of RSV collected prospectively from infants with different degrees of RSV disease severity were evaluated in vitro, holding host factors constant, so as to assess whether isolates induced phenotypically different cytokine/chemokine concentrations in a human lung epithelial cell line. Sixty-seven RSV isolates from previously healthy infants (38 hospitalized for acute RSV infection (severe disease) and 29 never requiring hospitalization (mild disease)) were inoculated into A549, lung epithelial cells at precisely controlled, low multiplicity of infection to mimic natural infection. Cultures were evaluated at 48 hours, 60 hours, and 72 hours to evaluate area under the curve (AUC) cytokine/chemokine induction. RESULTS: Cells infected with isolates from severely ill infants produced higher mean concentrations of all cytokine/chemokines tested (IL-1α, IL-6, IL-8 and RANTES) at all-time points tested. RSV isolates collected from infants with severe disease induced significantly higher AUCIL-8 and AUCRANTES secretion in infected cultures than mild disease isolates (p=0.028 and p=0.019 respectively). IL-8 and RANTES concentrations were 4 times higher at 48 hours for these severely ill infant isolates. Additionally, 38 isolates were evaluated at all-time points for quantity of virus. RSV concentration significantly correlated with both IL-8 and RANTES at all-time points. Neither cytokine/chemokine concentrations nor RSV concentrations were associated with RSV subgroup. DISCUSSION: Infants’ RSV disease severity differences may be due in part to intrinsic viral strain-specific characteristics.
format Online
Article
Text
id pubmed-4603536
institution National Center for Biotechnology Information
language English
publishDate 2015
record_format MEDLINE/PubMed
spelling pubmed-46035362015-10-13 Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants Thompson, Tonya M Roddam, Philippa L Harrison, Lisa M Aitken, Jody A DeVincenzo, John P Clin Microbiol Article BACKGROUND: There is a wide range of severity of respiratory syncytial viral (RSV) disease in previously healthy infants. Host factors have been well demonstrated to contribute to disease severity differences. However the possibility of disease severity differences being produced by factors intrinsic to the virus itself has rarely been studied. METHODS: Low-passage isolates of RSV collected prospectively from infants with different degrees of RSV disease severity were evaluated in vitro, holding host factors constant, so as to assess whether isolates induced phenotypically different cytokine/chemokine concentrations in a human lung epithelial cell line. Sixty-seven RSV isolates from previously healthy infants (38 hospitalized for acute RSV infection (severe disease) and 29 never requiring hospitalization (mild disease)) were inoculated into A549, lung epithelial cells at precisely controlled, low multiplicity of infection to mimic natural infection. Cultures were evaluated at 48 hours, 60 hours, and 72 hours to evaluate area under the curve (AUC) cytokine/chemokine induction. RESULTS: Cells infected with isolates from severely ill infants produced higher mean concentrations of all cytokine/chemokines tested (IL-1α, IL-6, IL-8 and RANTES) at all-time points tested. RSV isolates collected from infants with severe disease induced significantly higher AUCIL-8 and AUCRANTES secretion in infected cultures than mild disease isolates (p=0.028 and p=0.019 respectively). IL-8 and RANTES concentrations were 4 times higher at 48 hours for these severely ill infant isolates. Additionally, 38 isolates were evaluated at all-time points for quantity of virus. RSV concentration significantly correlated with both IL-8 and RANTES at all-time points. Neither cytokine/chemokine concentrations nor RSV concentrations were associated with RSV subgroup. DISCUSSION: Infants’ RSV disease severity differences may be due in part to intrinsic viral strain-specific characteristics. 2015-06-29 2015-06 /pmc/articles/PMC4603536/ /pubmed/26473163 http://dx.doi.org/10.4172/2327-5073.1000206 Text en http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Article
Thompson, Tonya M
Roddam, Philippa L
Harrison, Lisa M
Aitken, Jody A
DeVincenzo, John P
Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants
title Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants
title_full Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants
title_fullStr Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants
title_full_unstemmed Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants
title_short Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants
title_sort viral specific factors contribute to clinical respiratory syncytial virus disease severity differences in infants
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603536/
https://www.ncbi.nlm.nih.gov/pubmed/26473163
http://dx.doi.org/10.4172/2327-5073.1000206
work_keys_str_mv AT thompsontonyam viralspecificfactorscontributetoclinicalrespiratorysyncytialvirusdiseaseseveritydifferencesininfants
AT roddamphilippal viralspecificfactorscontributetoclinicalrespiratorysyncytialvirusdiseaseseveritydifferencesininfants
AT harrisonlisam viralspecificfactorscontributetoclinicalrespiratorysyncytialvirusdiseaseseveritydifferencesininfants
AT aitkenjodya viralspecificfactorscontributetoclinicalrespiratorysyncytialvirusdiseaseseveritydifferencesininfants
AT devincenzojohnp viralspecificfactorscontributetoclinicalrespiratorysyncytialvirusdiseaseseveritydifferencesininfants